CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer

Clinical trial NCT02067741 · TERMINATED

Trial details

NCT number: NCT02067741
Sponsor: Swiss Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Adenocarcinoma Breast Cancer

Start date: 2016-06-14
Primary completion: 2018-08-02
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.